Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

نویسندگان

  • Raymond H Chan
  • Barry J Maron
  • Iacopo Olivotto
  • Michael J Pencina
  • Gabriele Egidy Assenza
  • Tammy Haas
  • John R Lesser
  • Christiane Gruner
  • Andrew M Crean
  • Harry Rakowski
  • James E Udelson
  • Ethan Rowin
  • Massimo Lombardi
  • Franco Cecchi
  • Benedetta Tomberli
  • Paolo Spirito
  • Francesco Formisano
  • Elena Biagini
  • Claudio Rapezzi
  • Carlo Nicola De Cecco
  • Camillo Autore
  • E Francis Cook
  • Susie N Hong
  • C Michael Gibson
  • Warren J Manning
  • Evan Appelbaum
  • Martin S Maron
چکیده

BACKGROUND Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden death in the young, although not all patients eligible for sudden death prevention with an implantable cardioverter-defibrillator are identified. Contrast-enhanced cardiovascular magnetic resonance with late gadolinium enhancement (LGE) has emerged as an in vivo marker of myocardial fibrosis, although its role in stratifying sudden death risk in subgroups of HCM patients remains incompletely understood. METHODS AND RESULTS We assessed the relation between LGE and cardiovascular outcomes in 1293 HCM patients referred for cardiovascular magnetic resonance and followed up for a median of 3.3 years. Sudden cardiac death (SCD) events (including appropriate defibrillator interventions) occurred in 37 patients (3%). A continuous relationship was evident between LGE by percent left ventricular mass and SCD event risk in HCM patients (P=0.001). Extent of LGE was associated with an increased risk of SCD events (adjusted hazard ratio, 1.46/10% increase in LGE; P=0.002), even after adjustment for other relevant disease variables. LGE of ≥15% of LV mass demonstrated a 2-fold increase in SCD event risk in those patients otherwise considered to be at lower risk, with an estimated likelihood for SCD events of 6% at 5 years. Performance of the SCD event risk model was enhanced by LGE (net reclassification index, 12.9%; 95% confidence interval, 0.3-38.3). Absence of LGE was associated with lower risk for SCD events (adjusted hazard ratio, 0.39; P=0.02). Extent of LGE also predicted the development of end-stage HCM with systolic dysfunction (adjusted hazard ratio, 1.80/10% increase in LGE; P<0.03). CONCLUSIONS Extensive LGE measured by quantitative contrast enhanced CMR provides additional information for assessing SCD event risk among HCM patients, particularly patients otherwise judged to be at low risk.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Apical Hypertrophic Cardiomyopathy in a Case with Chest Pain and Family History of Sudden Cardiac Death: A Case Report

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, which is caused by a multitude of mutations in genes encoding proteins of the cardiac sarcomere (1). Apical hypertrophic cardiomyopathy (AHCM) is an uncommon type of HCM. The sudden cardiac death is less likely to occur in the patients inflicted with AHCM (2). Herein, we presented the case of a 29-year-old man ...

متن کامل

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy

Background Although myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) may predict adverse outcomes among patients with hypertrophic cardiomyopathy (HCM), its precise role in risk stratification for sudden cardiac death (SCD) remains unresolved. Previous studies have relied on broad surrogate composite endpoints and were underpowered to a...

متن کامل

Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.

Although patients with hypertrophic cardiomyopathy (HCM) and without conventional risk factors for sudden death are generally considered at low risk, the magnitude of risk in such patients remains unknown, and additional markers of prognosis may permit more accurate risk stratification.1–3 We report a patient with HCM and without conventional risk factors who had a sustained life-threatening ve...

متن کامل

Refining the characterization of residual function in hypertrophic cardiomyopathy through remote segment 4D strain analysis

Background Quantitative assessment of late gadolinium enhancement (LGE) by cardiovascular magnetic resonance imaging (CMR) has been associated with an increased risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). However, patients with lesser degrees of LGE may still remain at high risk of adverse cardiac events due to the diffuse pathophysiology of HCM. Non-i...

متن کامل

Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis

Background Contrast-enhanced cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE) has emerged as an in vivo marker of myocardial fibrosis, although its significance in identifying high risk hypertrophic cardiomyopathy (HCM) patients remains unresolved. Previous meta-analyses have included studies with data involving overlapping patient populations, thus confounding eff...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Circulation

دوره 130 6  شماره 

صفحات  -

تاریخ انتشار 2014